<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Australia</title>
	<atom:link href="http://www.bioscreening.net/category/news-by-region/region-australia/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Green protein inhibits Alheimer&#8217;s, CSIRO scientists find</title>
		<link>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/</link>
		<comments>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 19:42:19 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[R & D]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/</guid>
		<description><![CDATA[BY NYSSA SKILTON MEDICAL REPORTER 18/11/2008 CSIRO scientists have developed a way to screen for compounds that can inhibit the progression of Alzheimer&#8217;s disease. The system involves using live yeast and a protein called Abeta fused to a fluorescent green protein, which comes from jellyfish. The scientists, working within CSIRO&#8217;s Preventive Health Flagship, published their [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/green-protein-inhibits-alheimers-csiro-scientists-find/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Scientists seek out Alzheimer&#8217;s enemies</title>
		<link>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/</link>
		<comments>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 19:24:14 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/</guid>
		<description><![CDATA[CSIRO scientists have developed a new system to screen for compounds that can inhibit one of the processes that takes place during the progression of Alzheimerâ€™s disease. In a paper published in the Journal of Alzheimerâ€™s Disease, folate is shown to be beneficial in the screening system. Lead author, CSIROâ€™s Dr Ian Macreadie says folate [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/scientists-seek-out-alzheimers-enemies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The increased sensitivity, functionality and vehicle mounted mobile capability of the Voice200, as well as its competitive pricing model, are raising strong commercial interest in the market</title>
		<link>http://www.bioscreening.net/2007/07/23/the-increased-sensitivity-functionality-and-vehicle-mounted-mobile-capability-of-the-voice200-as-well-as-its-competitive-pricing-model-are-raising-strong-commercial-interest-in-the-market/</link>
		<comments>http://www.bioscreening.net/2007/07/23/the-increased-sensitivity-functionality-and-vehicle-mounted-mobile-capability-of-the-voice200-as-well-as-its-competitive-pricing-model-are-raising-strong-commercial-interest-in-the-market/#comments</comments>
		<pubDate>Mon, 23 Jul 2007 19:40:09 +0000</pubDate>
		<dc:creator>Fred</dc:creator>
				<category><![CDATA[Australia]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/07/23/the-increased-sensitivity-functionality-and-vehicle-mounted-mobile-capability-of-the-voice200-as-well-as-its-competitive-pricing-model-are-raising-strong-commercial-interest-in-the-market/</guid>
		<description><![CDATA[Syft Technologies is launching the next generation of Sift-MS instrumentation, the Voice200, which it says delivers real-time identification and quantitation of volatile organic compounds (VOCs) at the push of a button. Geoff Peck CEO of Syft Technologies says: &#8216;The design criteria and market requirements for this next generation of instruments were exacting. &#8216;We set a [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/07/23/the-increased-sensitivity-functionality-and-vehicle-mounted-mobile-capability-of-the-voice200-as-well-as-its-competitive-pricing-model-are-raising-strong-commercial-interest-in-the-market/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cytopia Announces Major License and R&amp;D Collaboration</title>
		<link>http://www.bioscreening.net/2006/06/07/cytopia-announces-major-license-and-rd-collaboration/</link>
		<comments>http://www.bioscreening.net/2006/06/07/cytopia-announces-major-license-and-rd-collaboration/#comments</comments>
		<pubDate>Wed, 07 Jun 2006 22:19:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Australia]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/06/07/cytopia-announces-major-license-and-rd-collaboration/</guid>
		<description><![CDATA[MELBOURNE, Australia, June 4 /PRNewswire-FirstCall/ &#8212; Cytopia Ltd (ASX: CYT &#8211; News) today announced the signing of a global license and research and development collaboration with Novartis to develop orally active, small molecule therapeutics targeting JAK3 kinase for the prevention of transplant rejection and the treatment of multiple indications in autoimmune diseases such as rheumatoid [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/06/07/cytopia-announces-major-license-and-rd-collaboration/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>egoli Biotech &amp; Health News: AEI, EPT, NDL, SBP</title>
		<link>http://www.bioscreening.net/2005/08/19/egoli-biotech-health-news-aei-ept-ndl-sbp/</link>
		<comments>http://www.bioscreening.net/2005/08/19/egoli-biotech-health-news-aei-ept-ndl-sbp/#comments</comments>
		<pubDate>Fri, 19 Aug 2005 19:39:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Australia]]></category>
		<category><![CDATA[Business and Investment]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/08/19/egoli-biotech-health-news-aei-ept-ndl-sbp/</guid>
		<description><![CDATA[(AEI) AERIS TECHNOLOGIES LTD â€“3.0c to 77.0c; Advises that in conjunction with the University of New South Wales, it has been awarded a $540,000 Australian Research Council ARC Linkage Grant. The grant covers a period of 3 years from July 2005 and will fund research into substantially broadening the Aeris enzyme applications and product portfolio. [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/08/19/egoli-biotech-health-news-aei-ept-ndl-sbp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Software that automatically assesses a drug&#8217;s effect on nerve cells</title>
		<link>http://www.bioscreening.net/2005/06/21/software-that-automatically-assesses-a-drugs-effect-on-nerve-cells/</link>
		<comments>http://www.bioscreening.net/2005/06/21/software-that-automatically-assesses-a-drugs-effect-on-nerve-cells/#comments</comments>
		<pubDate>Tue, 21 Jun 2005 21:30:58 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Australia]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2005/06/22/software-that-automatically-assesses-a-drugs-effect-on-nerve-cells/</guid>
		<description><![CDATA[Potential new drugs for neurological disorders like Parkinson&#8217;s are being screened faster thanks to world-leading CSIRO software that automatically assesses a drug&#8217;s effect on nerve cells. The image analysis software will be highlighted at BIO2005, the world&#8217;s largest biotechnology conference, on 19-22 June in Philadelphia, USA. In the search for new pharmaceuticals, thousands of chemical [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2005/06/21/software-that-automatically-assesses-a-drugs-effect-on-nerve-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

